评估肺炎肠道炎作为肺移植并发症的评估
V Belloch Ripollés1, C F Muñoz Núñez1, A Fontana Bellorín2
1Servicio de Radiología, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
Radiologia
|August 1, 2024
概括
肺炎肠道病是肺移植接受者的罕见发现,发生在3.1%的患者中. 这种状况的特点是肠壁气体,通常呈现出轻微的症状,并以保守的方式管理.
科学领域:
- 胃肠病学 胃肠病学
- 肺部病理学 肺部病理学
- 放射学 放射学是一门学科.
背景情况:
- 肠道肺炎,肠壁中的气体,是与各种疾病相关的放射性迹象.
- 它的发生和肺移植接受者的重要性需要调查.
研究的目的:
- 为了确定肺移植患者肺炎肠道病的发病率.
- 为了探索其生理病理学和移植后的临床相关性.
主要方法:
- 对被诊断患有肠道肺炎的肺移植患者的回顾性分析.
- 收集人口统计,临床和成像数据,以评估关联和结果.
主要成果:
- 发生率为3.1% (17/546),移植后9-1270天开始 (平均198天).
- 大多数患者无症状或轻度症状,囊性,扩展性放射性发现.
- 肺发生在70%的人中;保守的管理是普遍的,平均解决时间为389天.
结论:
- 肺炎肠道炎是一种罕见的,晚期发作的并发症,在肺移植患者中具有不确定的病因.
- 它通常具有较低的临床意义,可以在没有进一步干预的情况下保守地管理.
相关概念视频
Pneumothorax-II
131
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
131
Pneumonia III: Complications and Assessment
194
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
194
Pneumonia I: Introduction
217
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
217
Pneumothorax-I
186
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
186
Pneumonia V: Nursing management and Prevention
2.0K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.0K
Pneumonia IV: Management
315
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
315


